Volitionrx Ltd (NYSE:VNRX) shares rallied 18.5% on Thursday after the company unveiled encouraging performance data for its ...

The Foresight CLARITY test offers greater prognostic accuracy than PET/CT scans in large B-cell lymphoma by detecting ctDNA-MRD negativity, indicating better patient outcomes. ctDNA-MRD testing showed ...

A small veterinary laboratory in California, VDI Labs, is helping more animals survive through early cancer detection – their new biomarker test will aid veterinarians and dog owners in the quest to ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces results from a clinical study demonstrating the high accuracy of its Nu.Q® Vet Feline assay in ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about the role of PSMA-PET Imaging versus PSA. Prostate specific antigen (PSA) is a ...

Circulating tumor DNA (ctDNA) minimal residual disease (MRD) assessment at treatment completion provides superior prognostic accuracy compared with PET in large B-cell lymphoma. The CLARITY assay ...

No pet owner goes into adopting with the thought that their furry friend is going to get cancer one day. Oftentimes, early signs of cancer are missed because of not knowing what to look for or not ...

Recently, I had a scare involving the health of my dog, Bowie. During a dental cleaning, his vet discovered a small, suspicious spot on his jaw and biopsied it out of an abundance of caution. The ...